DIALYSIS · CCN 672734

DaVita Horizon Dialysis

HOUSTON, TX 77084

DialysisProfitDaVita
$8.2M
TOTAL REVENUE
42.2%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$8.2M
Total costs
$4.8M
Operating income (rev − costs)
$3.5M
Operating margin
42.2%
Total charges
$8.0M
Total treatments
16,999
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.2853—
Fistula Rate
DFC_FISTULA_RATE
63.7113—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.4536—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
144.2123—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.72——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
13113—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.1460—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
26.7126—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
17.690—
Standardized ED Visits Ratio
DFC_SEDR
0.6658—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
26.353—